Gemmer Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Gemmer Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-59	Closed	-$3K	–	1509
2019 Q4	$3K	Hold	59	–	–	﹤0.01%	1200
2019 Q3	$2K	Buy	59 +13	+28%	+$561	﹤0.01%	1295
2019 Q2	$2K	Buy	46 +10	+28%	+$526	﹤0.01%	1289
2019 Q1	$2K	Buy	+36	New	+$2.47K	﹤0.01%	1310

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gemmer Asset Management's BEAT Position: Q1 2020 in Review

Gemmer Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 59 shares — an estimated $3K sold.

Gemmer Asset Management first reported a position in BEAT in Q1 2019 and held it in 4 quarters. The position peaked at $3K in Q4 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Gemmer Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
Gemmer Asset Management sold 59 BioTelemetry, Inc. shares in Q1 2020, an estimated $3K.
Gemmer Asset Management first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 4 quarters.
Gemmer Asset Management's BioTelemetry, Inc. position peaked at $3K in Q4 2019.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Gemmer Asset Management's 13F filing for Q1 2020, filed 1 May 2020.